CEA itself — the underlying genetic condition and the structural changes it creates — is not surgically treatable. We cannot repair hypoplastic choroid or fill a coloboma. What we can sometimes treat are the complications that arise from those underlying changes: retinal detachment, intraocular haemorrhage, and in some cases, prophylactic stabilisation of tissue at high risk of detachment. The field of canine ophthalmic surgery has advanced considerably in recent decades, and what was once uniformly hopeless in terms of severe CEA complications is now sometimes surgically manageable. Understanding the realistic options helps owners and breeders navigate difficult decisions with accurate information.
CEA Itself: Not Surgically Correctable
I want to be clear from the outset to avoid false hope. The choroidal hypoplasia that represents mild CEA is a permanent structural feature — the tissue failed to develop normally and that developmental window cannot be re-opened. We do not surgically supplement or reconstruct hypoplastic choroid. Dogs with choroidal hypoplasia alone are not surgical candidates and do not need any intervention; their condition is stable and their vision is normal.
Colobomas — the pit-like defects adjacent to the optic disc seen in more severely affected dogs — are also not directly surgically repaired. The tissue defect itself is permanent. However, the complications that colobomas predispose to can sometimes be addressed surgically, which is where treatment options become relevant.
Laser Photocoagulation: Prophylactic Retinal Attachment
In dogs with significant colobomas identified on ophthalmoscopic examination, there is a real risk of subsequent retinal detachment. The colobomatous tissue creates structural weakness at the coloboma margins and may allow fluid to accumulate beneath the retina, leading to detachment. Laser photocoagulation can be used prophylactically to create adhesions between the retina and underlying tissue around the margins of the coloboma, reducing the risk of detachment.
The procedure uses a laser — most commonly a diode laser — to create controlled focal burns in the retinal tissue surrounding the coloboma. The resulting inflammatory response creates firm adhesions between the retinal layers and the underlying choroid and sclera, "tacking down" the retina in the areas most vulnerable to detachment. This is analogous to the laser treatment used prophylactically in human patients with high-risk retinal tears.
Candidacy for Prophylactic Laser
Not all dogs with colobomas are candidates for prophylactic laser treatment, nor does every dog with colobomas require it. My criteria for recommending prophylactic laser include:
- Moderate to large coloboma (Grade 3 or above in my grading system)
- Presence of early retinal changes around the coloboma margins suggesting impending detachment
- Young dog (detachment risk is highest in the first two years)
- Owner willing and able to manage post-procedure care and follow-up
Dogs with small colobomas and no signs of retinal stress, or dogs that have reached three years of age without complications, are generally not recommended for prophylactic laser. The natural history of CEA suggests that dogs who have not experienced detachment by 24-30 months are considerably less likely to do so thereafter, making prophylaxis at that stage difficult to justify against the procedural risks and cost.
Retinal Detachment Surgery
When retinal detachment occurs — whether from CEA or any other cause — the window for surgical intervention is narrow and the outcome is uncertain. I have detailed the recognition and emergency management of CEA-associated retinal detachment elsewhere; here I focus on the surgical options specifically.
Scleral Buckling
Scleral buckling involves placing a silicone band or explant around the outside of the eye to indent the scleral wall and bring it into contact with the detached retina. This is a well-established technique in human ophthalmology that has been adapted for veterinary use. In dogs with CEA-associated detachment, scleral buckling can achieve retinal reattachment in carefully selected cases.
The procedure is technically demanding and requires an experienced veterinary ophthalmological surgeon. It is typically performed under general anaesthesia with microsurgical instrumentation. Postoperative management includes restricted activity, topical and systemic medications, and close monitoring for complications including infection, implant extrusion, and re-detachment.
Success rates in canine CEA-related detachments are variable — perhaps 40-60% achieve meaningful visual recovery in published case series, though my own experience suggests that results depend heavily on how quickly surgery is performed after detachment onset and the extent of the detachment at the time of surgery. Detachments treated within 48-72 hours of onset have substantially better outcomes than those present for a week or more.
Vitreoretinal Surgery
For complex or recurrent detachments, or those associated with significant intraocular haemorrhage, vitreoretinal surgery offers more direct access to the posterior segment of the eye. This approach involves inserting small-gauge instruments into the vitreous cavity to remove blood or fibrous material, drain subretinal fluid, and directly manipulate the retina back into position.
Vitreoretinal surgery in small animals requires specialist training and equipment available at only a handful of veterinary ophthalmology centres worldwide. It is expensive, carries significant procedural risks, and is generally reserved for cases where scleral buckling alone is unlikely to succeed. When it works, the visual recovery can be remarkable. When it fails, the eye may require enucleation or at minimum provide no useful vision.
Realistic Expectations
I always have an honest conversation with owners before recommending retinal reattachment surgery. The reality is that even successful anatomical reattachment does not guarantee visual recovery equivalent to an unaffected eye. Dogs who have had a detached retina for several days or weeks may have experienced photoreceptor damage that is irreversible even if the retina is successfully reattached. The goal of surgery is to preserve whatever vision can be preserved, not to restore normal function.
I have seen cases where owners chose not to pursue surgery and instead focused on supporting their dog's quality of life with the remaining vision, which in monocular cases can be entirely adequate. I have also seen cases where surgical intervention preserved functional vision that would otherwise have been permanently lost. The decision belongs to the owner, informed by my honest assessment of the specific case.
Management of Intraocular Haemorrhage
Haemorrhage into the vitreous cavity — which can occur when abnormal vessels within colobomatous tissue rupture — is managed primarily medically in the acute phase. Systemic anti-inflammatory medications and activity restriction allow the blood to be reabsorbed in many cases. If haemorrhage is recurrent or persistent, or if it is associated with retinal detachment, surgical drainage may be considered.
Owners who notice a sudden change in their dog's eye appearance — cloudiness, redness, or what appears to be blood in the eye — should seek emergency veterinary attention. Time matters for both haemorrhage and detachment. Owners of dogs known to have colobomas should read about recognition and emergency response so they can act quickly if complications develop.
Enucleation
In cases where a CEA-affected eye is blind, painful, and unresponsive to treatment, enucleation — surgical removal of the eye — may be recommended. This is not a failure of treatment but a compassionate intervention to eliminate pain and prevent further complications. Dogs adapt remarkably well to monocular vision, and many owners are surprised by how little the removed eye affects their dog's quality of life.
The decision to enucleate is never taken lightly, and I always explore all reversible options before recommending it. But in the rare cases where a CEA-affected eye has become a source of ongoing pain and dysfunction, removal is a kind and appropriate choice.
Emerging Therapies
Research into gene therapy for inherited retinal conditions in dogs is advancing, with some conditions showing genuine promise for treatment through viral vector delivery of functional gene copies. CEA presents particular challenges for gene therapy because the developmental window during which the choroid forms is restricted to foetal life, and the structural changes are already established before birth. Gene therapy might theoretically prevent CEA if administered in utero or in the first days of life before the developmental window closes, but this is far from clinical practice.
Neuroprotective strategies — pharmacological approaches to reduce progressive retinal damage in at-risk eyes — are an area of active research. None are currently validated for routine clinical use in CEA specifically, though some practitioners use antioxidant supplementation in dogs with significant colobomas on the rationale that reducing oxidative stress may slow any progressive element.
The Decision Framework
When an owner contacts me about a CEA-affected dog that has developed complications, I guide the conversation through four questions: What is the current visual status of the eye? What is the underlying structural explanation for the complication? What are the realistic outcomes with and without intervention? What are the owner's circumstances and values regarding surgical investment?
There is no universal right answer. A competition dog whose working life depends on vision may justify aggressive surgical intervention that would not be appropriate for an older companion dog. An owner with access to specialist facilities and the resources to support intensive postoperative care is in a different position from someone in a rural area far from expertise. My role is to provide complete information and honest assessment, not to impose a single correct response.
For the vast majority of CEA-affected dogs, none of this complexity is relevant — they have mild disease, normal vision, and will never need any treatment at all. The practical experience of living with a CEA-affected dog for most owners is entirely unremarkable from a medical management perspective.